FOS and Alzheimer disease: Through transcriptomic analysis, the study elucidated for the first time that GNN can activate the OXT/ERK/Fos pathway to break the malignant cycle of ROS-neuroinflammation, inhibiting the amplification effect of early AD pathological damage.